SoPharma is a Moroccan pharmaceutical laboratory founded in 2022 by two entrepreneurs, whose mission is to make the most innovative healthcare solutions available to as many people as possible.
SoPharma's DNA is based on 3 pillars: People, Health, Innovation - the human element being at the heart of its strategy.
The experience, values and network of its founders have enabled SoPharma to forge various types of partnerships with leading international companies for import, manufacturing and distribution of healthcare solutions.
Since its creation, SoPharma has focused on 2 Business Units in the Africa/MENA region:
- "Health and Comfort" dedicated to food supplements;
- "Skincare By SoPharma", dedicated to cosmetics and dermocosmetics.
The group's current strategy is to distribute exclusively under license products from international laboratories, as well as its own ranges.
In addition, SoPharma has undertaken the construction of a drug manufacturing plant in the Casablanca region. In Phase 1, this unit will be dedicated to the following 3 therapeutic areas: Central Nervous System, Oncology and Cardiometabolism.
The Group's ambition is to become a major player in healthcare innovation from Morocco to Africa, the Middle East and Europe.
People. Health. Innovation.
MANIFESTO
We believe that the two fundamental pillars of any society are health and education.
This is even truer in Africa and the Middle East.
We also believe that entrepreneurship is a powerful response to these fundamental and vital issues.
The Covid-19 crisis has highlighted our continent's vulnerability in terms of industrial and health sovereignty. We founded SoPharma with the aim of improving people's health and giving them access to the most innovative healthcare solutions.
Africa and the Middle East are lands of opportunity, but they are not easy to understand. Market analysis is not enough. It's essential to be firmly rooted in the region and to pay close attention to it.
SoPharma is built on a long-term vision, a pragmatic strategy, and unfailing agility to manage rapid growth.
People. Health. Innovation.
IN FIGURES
40 employees
including 40% women
100+ clients in 15 cities in Morocco, Africa and the Middle East
An EU GMP production site under construction
